- Home
- Publications
- Publication Search
- Publication Details
Title
Enzyme replacement therapy: lessons learned and emerging questions
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 3, Issue 3, Pages 293-305
Publisher
Informa Healthcare
Online
2015-02-19
DOI
10.1517/21678707.2015.1017469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)-10-year follow-up of patients who previously participated in an MPS VI survey study
- (2014) Roberto Giugliani et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Lysosomal storage diseases as disorders of autophagy
- (2014) Carmine Settembre et al. Autophagy
- Pharmacological chaperone therapy for lysosomal storage diseases
- (2014) Giancarlo Parenti et al. Future Medicinal Chemistry
- Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis
- (2014) Saskia M. Rombach et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years
- (2014) Rosella Tomanin et al. Orphanet Journal of Rare Diseases
- Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
- (2014) Laura van Dussen et al. Orphanet Journal of Rare Diseases
- The Effect of Recombinant Human Iduronate-2-Sulfatase (Idursulfase) on Growth in Young Patients with Mucopolysaccharidosis Type II
- (2014) Zbigniew Żuber et al. PLoS One
- Newborn screening for lysosomal storage disorders and other neuronopathic conditions
- (2013) Dietrich Matern et al. Developmental Disabilities Research Reviews
- The final frontier - crossing the blood-brain barrier
- (2013) William S. Sly et al. EMBO Molecular Medicine
- Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI
- (2013) Paul R. Harmatz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
- (2013) Dafne D.G. Horovitz et al. MOLECULAR GENETICS AND METABOLISM
- Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice
- (2013) Guilherme Baldo et al. MOLECULAR GENETICS AND METABOLISM
- Effect of rapid cessation of enzyme replacement therapy: A report of 5 more cases
- (2013) Agnieszka Jurecka et al. MOLECULAR GENETICS AND METABOLISM
- Early initiation of enzyme replacement therapy for the mucopolysaccharidoses
- (2013) Joseph Muenzer MOLECULAR GENETICS AND METABOLISM
- Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
- (2013) Marion M Brands et al. Orphanet Journal of Rare Diseases
- The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?
- (2013) Robin Lachmann et al. Orphanet Journal of Rare Diseases
- Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
- (2013) Sean N Prater et al. Orphanet Journal of Rare Diseases
- Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
- (2013) Saskia M Rombach et al. Orphanet Journal of Rare Diseases
- Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)
- (2013) Shunji Tomatsu et al. Expert Opinion on Orphan Drugs
- The emerging phenotype of long-term survivors with infantile Pompe disease
- (2012) Sean N. Prater et al. GENETICS IN MEDICINE
- Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
- (2012) Jagat Kanwar et al. International Journal of Nanomedicine
- Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy
- (2012) E. Braunlin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Effect of rapid cessation of enzyme replacement therapy: A report of 5 cases and a review of the literature
- (2012) Agnieszka Jurecka et al. MOLECULAR GENETICS AND METABOLISM
- A shortcut to the lysosome: The mannose-6-phosphate-independent pathway
- (2012) Maria Francisca Coutinho et al. MOLECULAR GENETICS AND METABOLISM
- Enzyme Replacement Therapy in an Attenuated Case of Mucopolysaccharidosis Type I (Scheie Syndrome): A 6.5-Year Detailed Follow-Up
- (2012) Agnieszka Jurecka et al. PEDIATRIC NEUROLOGY
- Spinal Cord Compression in Maroteaux-Lamy Syndrome: Case Report and Review of the Literature with Effects of Enzyme Replacement Therapy
- (2012) Agnieszka Jurecka et al. PEDIATRIC NEUROSURGERY
- Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up
- (2011) A Tylki- Szymanska et al. ACTA PAEDIATRICA
- In memory of Alan M. Gewirtz
- (2011) Susan E. Shetzline CANCER BIOLOGY & THERAPY
- Therapies for Neurological Disease in the Mucopolysaccharidoses
- (2011) Donald S. Anson et al. CURRENT GENE THERAPY
- The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
- (2011) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- Maroteaux–Lamy Syndrome (Mucopolysaccharidosis VI) Presenting as Familial Myelopathy
- (2011) Manish Modi et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy
- (2011) C. M. van Gelder et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The use of dried blood spot samples in the diagnosis of lysosomal storage disorders — Current status and perspectives
- (2011) Arnold J. Reuser et al. MOLECULAR GENETICS AND METABOLISM
- Spinal cord compression in young children with type VI mucopolysaccharidosis
- (2011) Dafne Dain Gandelman Horovitz et al. MOLECULAR GENETICS AND METABOLISM
- Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
- (2011) Carla EM Hollak et al. Orphanet Journal of Rare Diseases
- TFEB Links Autophagy to Lysosomal Biogenesis
- (2011) C. Settembre et al. SCIENCE
- Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
- (2010) Roberto Giugliani et al. GENETICS AND MOLECULAR BIOLOGY
- Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients
- (2010) G. V. Coppa et al. GLYCOBIOLOGY
- Efficacy of recombinant human α-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients
- (2010) Anna Tylki-Szymanska et al. JOURNAL OF INHERITED METABOLIC DISEASE
- High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
- (2010) Juna M. de Vries et al. MOLECULAR GENETICS AND METABOLISM
- Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)
- (2010) Gabor E. Linthorst et al. MOLECULAR GENETICS AND METABOLISM
- New Therapeutic Approaches to Mendelian Disorders
- (2010) Harry C. Dietz NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease
- (2010) Ans T. van der Ploeg et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
- (2010) Jeffrey H. Grubb et al. REJUVENATION RESEARCH
- Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
- (2010) Michael Beck Therapeutics and Clinical Risk Management
- Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
- (2009) Carla E.M. Hollak et al. BLOOD CELLS MOLECULES AND DISEASES
- Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study
- (2009) JJ McGill et al. CLINICAL GENETICS
- Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
- (2009) Marc Nicolino et al. GENETICS IN MEDICINE
- Management of neuronopathic Gaucher disease: Revised recommendations
- (2009) A. Vellodi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Recommendations on Diagnosis, Treatment, and Monitoring for Gaucher Disease
- (2009) Ana Maria Martins et al. JOURNAL OF PEDIATRICS
- Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis
- (2009) María Verónica Muñoz-Rojas et al. MOLECULAR GENETICS AND METABOLISM
- Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
- (2009) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
- (2009) Priya S Kishnani et al. PEDIATRIC RESEARCH
- Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-up
- (2009) O. Gabrielli et al. PEDIATRICS
- Sorting of lysosomal proteins
- (2008) Thomas Braulke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Structure of Glycosaminoglycans and their Interactions with Proteins
- (2008) Neha S. Gandhi et al. Chemical Biology & Drug Design
- Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3
- (2008) Anouk C. Vedder et al. MOLECULAR GENETICS AND METABOLISM
- Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
- (2008) C.E.M. Hollak et al. MOLECULAR GENETICS AND METABOLISM
- Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I
- (2008) L. A. Clarke et al. PEDIATRICS
- Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy
- (2007) M. Langeveld et al. BLOOD CELLS MOLECULES AND DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now